跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Vivanta Generics S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 26, 2025
Approval ID
7de39c888c12b9dd
Company
Vivanta Generics S.R.O.
Type
Standard
Approval Details
Approval Id
7de39c888c12b9dd
Drug Cima Aemps Name
BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
90411
Holder Company Name
Vivanta Generics S.R.O.
Marketing Company Name
Vivanta Generics S.R.O. Sucursal En Espana
Authorization Date
2025-06-26
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Vivanta Generics S.R.O.
Active Ingredients
BOSUTINIB DIHIDRATO
427,16 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 26, 2025
Approval ID
7de39c888c12b9dd
Type
Standard
Back to CIMA-AEMPS Approvals